Acadian Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,340
Closed -$160K 1869
2021
Q4
$160K Sell
10,340
-474
-4% -$9.05K ﹤0.01% 1281
2021
Q3
$242K Buy
10,814
+4,253
+65% +$93.4K ﹤0.01% 1246
2021
Q2
$150K Sell
6,561
-180,702
-96% -$3.8M ﹤0.01% 1523
2021
Q1
$3.85M Buy
+187,263
New +$4.26M 0.02% 537
2017
Q2
Sell
-4,156
Closed -$49K 1650
2017
Q1
$49K Buy
+4,156
New +$47.6K ﹤0.01% 1246

Other funds holding MYOV

Acadian Asset Management's MYOV Position: Q1 2022 in Review

Acadian Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 10,340 shares — an estimated $160K sold.

Acadian Asset Management first reported a position in MYOV in Q1 2017 and held it in 5 quarters. The position peaked at $3.85M in Q1 2021. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

  • Acadian Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
  • Acadian Asset Management sold 10,340 Myovant Sciences Ltd. shares in Q1 2022, an estimated $160K.
  • Acadian Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 5 quarters.
  • Acadian Asset Management's Myovant Sciences Ltd. position peaked at $3.85M in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.